The estimated Net Worth of Robert S Murley is at least $730 Mille dollars as of 14 January 2022. Mr. Murley owns over 87 units of Stericycle stock worth over $264,934 and over the last 10 years he sold SRCL stock worth over $160,400. In addition, he makes $304,960 as Independent Chairman of the Board at Stericycle.
Sign up
Mr. Murley SRCL stock SEC Form 4 insiders trading
Robert has made over 11 trades of the Stericycle stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 87 units of SRCL stock worth $5,365 on 14 January 2022.
The largest trade he's ever made was selling 10,000 units of Stericycle stock on 9 March 2017 worth over $160,400. On average, Robert trades about 1,178 units every 53 days since 2015. As of 14 January 2022 he still owns at least 4,296 units of Stericycle stock.
You can see the complete history of Mr. Murley stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Murley biography
Robert S. Murley serves as Independent Chairman of the Board of the Company. Mr. Murley is a Senior Adviser to Credit Suisse, LLC, a financial services company. From 1975 to April 2012, Mr. Murley was employed by Credit Suisse, LLC and its predecessors. In 2005, he was appointed Chairman of Investment Banking in the Americas. Prior to that time, Mr. Murley headed the Global Industrial and Services Group within the Investment Banking Division, as well as the Chicago investment banking office. He was named a Managing Director in 1984 and appointed a Vice Chairman in 1998. Mr. Murley is a member of the board of directors of Health Insurance Innovations Inc., of privately held Brown Advisory Incorporated, and of the board of advisors of Harbour Group. He was formerly on the board of directors of Stone Energy Corporation and Apollo Education Group, Inc. Mr. Murley is an Emeritus Charter Trustee of Princeton University, a Trustee and the former Chairman of the Board of the Educational Testing Service in Princeton, New Jersey, is Vice Chairman of the Board of the Ann & Robert Lurie Children’s Hospital of Chicago and Chair of the Board of the Lurie Children’s Foundation, is a Trustee of the Museum of Science & Industry in Chicago, Illinois, is Chairman of the Board of the UCLA Anderson Board of Advisors.
What is the salary of Robert Murley?
As the Independent Chairman of the Board of Stericycle, the total compensation of Robert Murley at Stericycle is $304,960. There are 9 executives at Stericycle getting paid more, with Cindy Miller having the highest compensation of $3,215,910.
How old is Robert Murley?
Robert Murley is 70, he's been the Independent Chairman of the Board of Stericycle since 2018. There are 1 older and 24 younger executives at Stericycle. The oldest executive at Stericycle Inc. is Veronica Hagen, 74, who is the Independent Director.
What's Robert Murley's mailing address?
Robert's mailing address filed with the SEC is 2355 WAUKEGAN ROAD, , BANNOCKBURN, IL, 60015.
Insiders trading at Stericycle
Over the last 22 years, insiders at Stericycle have traded over $161,740,081 worth of Stericycle stock and bought 27,280 units worth $1,574,920 . The most active insiders traders include Jack W Schuler, John Connaughton e James Reid Anderson. On average, Stericycle executives and independent directors trade stock every 23 days with the average trade being worth of $835,752. The most recent stock trade was executed by Jesse Joel Jr Hackney on 16 May 2024, trading 3,620 units of SRCL stock currently worth $223,245.
What does Stericycle do?
stericycle is a global services company. we provide highly specialized solutions serving healthcare organizations and commercial businesses of every size and shape. throughout the last 25 years, we have grown from a small start-up in medical waste management into a leader across a range of increasingly complex and highly regulated arenas, such as: • brand protection solutions • environmental & sustainable solutions • patient & customer communication solutions • regulated waste management & compliance solutions from the start we have challenged the status quo of what a business solution can be. by identifying unmet needs, we have redefined and transformed multiple industries from a narrowly defined service category to a robust suite of solutions that customers need and want. our success with this strategy has landed stericycle among the fortune 1000 list and forbes 25 most innovative companies. a publicly-traded company with $2.5 billion in 2014 revenue, our core purpose is to
What does Stericycle's logo look like?
Complete history of Mr. Murley stock trades at Health Insurance Innovations e Stericycle
Stericycle executives and stock owners
Stericycle executives and other stock owners filed with the SEC include:
-
Cindy Miller,
President, Chief Executive Officer, Director -
Cindy J. Miller,
Pres, CEO & Director -
Janet H. Zelenka,
Exec. VP, CFO & Chief Information Officer -
Daniel Ginnetti,
Executive Vice President - International -
Janet Zelenka,
Chief Financial Officer, Executive Vice President, Chief Information Officer -
Kurt Rogers,
Executive Vice President, General Counsel and Corporate Secretary -
Joseph Reuter,
Executive Vice President and Chief People Officer -
Stephen Cory White,
Exec. VP & Chief Commercial Officer -
Kurt M. Rogers,
Exec. VP, Gen. Counsel & Corp. Sec. -
Robert Murley,
Independent Chairman of the Board -
Brian Anderson,
Independent Director -
Lynn Bleil,
Independent Director -
Michael Zafirovski,
Independent Director -
Kay Priestly,
Independent Director -
Veronica Hagen,
Independent Director -
Thomas Chen,
Independent Director -
J. Joel Hackney,
Independent Director -
Stephen Hooley,
Independent Director -
S. Cory White,
Executive Vice President and Chief Commercial Officer -
Richard Moore,
Executive Vice President - North American Operations -
Dominic Culotta,
Executive Vice President and Chief Engineer -
Michael Weisman,
Executive Vice President, Chief Ethics and Compliance Officer -
Richard Michael Moore,
Exec. VP of North American Operations -
Joseph Anthony Reuter,
Exec. VP & Chief People Officer -
Michael S. Weisman,
Exec. VP and Chief Ethics & Compliance Officer -
Andrew Ellis,
VP of Investor Relations -
Daniel V. Ginnetti,
Exec. VP of International -
Jennifer Koenig,
VP of Corp. Communications & Investor Relations -
Richard Joseph Hoffman,
Sr. VP & Chief Accounting Officer -
Richard J Hoffman,
SVP & CHIEF ACCOUNTING OFFICER -
John P Schetz,
Sr Counsel M & A -
Thomas D Brown,
Director -
Mike S Zafirovski,
Director -
John Patience,
Director -
Jack W Schuler,
Chairman -
Brenda R Frank,
EVP & Chief People Officer -
Brent Arnold,
President, USA/Canada -
Ruth Ellen Abdulmassih,
Executive Vice President -
Rodney F Dammeyer,
Director -
Charles A Alutto,
President, USA -
Robert Guice,
Executive Vice President, Intl -
David W. Stahl,
EVP and CIO -
William J. Seward,
EVP, Chief Commercial Officer -
James Reid Anderson,
Director -
Mark C Miller,
CEO -
Michael J Collins,
President, Pharma Services -
Shan Sacranie,
Exec Vice Pres International -
Richard L Foss,
EXVP -
Richard T Kogler,
COO -
Richard J Marasco,
Exec VP Corp Mergers & Acquis -
Thomas R Reusche,
Director -
L John Wilkerson,
Director -
Jonathan T Md Lord,
Director -
Peter Vardy,
Director -
Brink Frank Jm Ten,
CFO -
William K Hall,
Director -
Ronald G Spaeth,
Director -
Patrick F Graham,
Director -
Anthony J Tomasello,
Vice President -
James J Martell,
Director -
John Connaughton,
Director -
James L Welch,
-
Victoria L Dolan,
-
Naren K Gursahaney,